Cannabis and Lower Back Pain

Not medical advice

This article is educational, not medical advice. Lower back pain has many causes — some benign, some serious (cauda equina syndrome, fracture, infection, malignancy). Red-flag symptoms like saddle anesthesia, bladder or bowel changes, progressive weakness, fever, or unexplained weight loss require urgent medical evaluation, not cannabis. Talk to a clinician familiar with your history before using cannabis for pain, especially if you take other medications, are pregnant, have a psychiatric history, or have cardiovascular disease.

Plain-language summary

Most adults will have low back pain at some point. About 20% develop chronic symptoms lasting beyond three months ^[1]. People reach for cannabis for two reasons: pain itself, and the sleep, anxiety, and muscle tension that come with it.

The overall picture from controlled trials: cannabinoids produce a small-to-moderate reduction in chronic pain scores compared to placebo, with effect sizes similar to other adjunctive pain medications Strong evidence^[2][3]. Most of that trial evidence is for neuropathic pain and cancer pain — not specifically low back pain. Trials specific to low back pain are few and small Weak / limited. Real-world surveys consistently show users report benefit and reduced use of other analgesics, but surveys are not controlled trials Weak / limited^[4].

What probably works

Chronic pain with a neuropathic component. When low back pain includes radiculopathy (sciatica), burning, or shooting pain from nerve root irritation, oral or oromucosal THC:CBD products show modest benefit in meta-analyses of chronic neuropathic pain Strong evidence^[2][5]. Nabiximols (Sativex, a 1:1 THC:CBD spray) is approved in several countries for multiple sclerosis spasticity and has chronic pain data; its trials are not specific to low back pain but include mixed chronic pain populations ^[6].

Pain-related sleep disruption. THC at low-to-moderate doses reduces sleep latency and nighttime awakenings in chronic pain patients Strong evidence^[3]. For people whose back pain wrecks their sleep, this is often the most reliable benefit they notice.

Reducing opioid dose. Observational and some prospective data suggest people using cannabis for chronic pain often reduce opioid use Weak / limited^[4][7]. This is not the same as proving cannabis treats the pain better — it may be substitution — but harm-reduction-wise it matters.

What might work

Muscle spasm. THC has documented antispasticity effects in MS Strong evidence^[6], but extrapolating to ordinary paraspinal muscle spasm is a leap. Patients report relief; controlled data for low back muscle spasm specifically is absent Anecdote.

CBD alone. CBD is the most heavily marketed product for back pain. Trial evidence for oral CBD in chronic non-cancer pain is mixed and mostly negative or null at the doses people actually take (typically 10–50 mg/day, versus 200–800 mg/day in trials) Weak / limited^[8]. Topical CBD has some signal in peripheral neuropathy Weak / limited^[9] but low back pain is mostly deep tissue — topicals are unlikely to reach the source.

Inflammation in degenerative disc disease. Cannabinoids reduce inflammatory markers in animal models of disc degeneration Weak / limited^[10]. No human disc disease trials exist.

What doesn't work or has weak evidence

Acute low back pain (the first few weeks). No controlled evidence supports cannabis for acute lumbar strain. Standard guidance — stay active, NSAIDs if appropriate, avoid bed rest — has far better evidence Strong evidence^[1].

"Indica for pain, sativa for energy." This is dispensary folklore, not pharmacology. Chemovar (the actual cannabinoid and terpene profile) varies enormously within both labels, and the indica/sativa dichotomy does not predict effects in any controlled study Disputed^[11].

Terpene-specific claims (e.g., myrcene as a sedative or muscle relaxant at cannabis-relevant doses). The often-repeated "0.5% myrcene threshold" has no clinical evidence behind it No data. Terpenes may contribute to effects (the "entourage effect"), but human evidence is thin and the specific marketing claims are unverified Disputed^[12].

Curing disc herniation or structural pathology. No evidence. Cannabis modulates pain perception; it does not repair tissue.

What we don't know

• Optimal THC:CBD ratio for low back pain specifically.
• Whether long-term use changes pain trajectory (does it help you recover, prevent recovery, or neither?).
• Whether vaporized flower, oral oils, and edibles have meaningfully different efficacy for the same person.
• Long-term effects on central sensitization. Some pain specialists worry chronic THC use may worsen central pain processing in some patients Weak / limited^[13].
• Interactions with common back-pain medications (gabapentinoids, SNRIs, opioids) at typical real-world doses.

These are genuine gaps, not rhetorical hedging. The trials needed to answer them mostly haven't been done.

Comparison with standard treatments

Current guidelines for chronic low back pain (ACP, NICE) prioritize exercise, physical therapy, and CBT as first-line, with NSAIDs, duloxetine, and limited opioids as pharmacological options ^[1][14]. None of these are dramatically effective either — chronic low back pain is hard to treat across the board.

Rough comparison of effect sizes from meta-analyses of chronic pain (not all low-back-specific):

• Exercise therapy: small-to-moderate, durable, very safe Strong evidence^[1].
• NSAIDs: small short-term benefit, GI/renal/cardiovascular risk with chronic use Strong evidence.
• Duloxetine: small benefit, side effects common Strong evidence.
• Opioids: short-term benefit, poor long-term outcomes, addiction risk Strong evidence.
• Cannabinoids: small-to-moderate benefit in chronic pain broadly; less low-back-specific data [evidence:weak to moderate]^[2][3].

Cannabis is plausibly in the same ballpark as the pharmacological options, with a different risk profile. It is not a substitute for exercise and rehabilitation.

Risks and side effects

• Cognitive and motor impairment, especially with THC. Don't drive impaired.
• Tolerance to THC analgesia develops within weeks. Many chronic users escalate doses without proportional benefit.
• Cannabis use disorder affects roughly 9–10% of adult users and up to ~30% of daily users Strong evidence^[15].
• Mental health: THC can trigger anxiety, paranoia, and, in vulnerable individuals, psychotic episodes.
• Cardiovascular: tachycardia and increased MI risk in the hour after use; relevant if you have heart disease Strong evidence^[16].
• Cannabinoid hyperemesis syndrome in heavy chronic users.
• Pregnancy: avoid. Associations with low birth weight and neurodevelopmental concerns Strong evidence^[17].
• Drug interactions: CBD inhibits CYP enzymes and can raise levels of warfarin, some antiepileptics, and others Strong evidence^[18].
• Withdrawal: irritability, sleep disturbance, appetite changes for 1–2 weeks after stopping heavy use.

A reasonable approach if you and your clinician decide to try cannabis: start low (e.g., 2.5 mg THC oral, or balanced THC:CBD), go slow, track whether function — not just pain score — actually improves over 4–6 weeks, and stop if it doesn't.

Sources

How this page was made

Related

• Cannabis and Chronic Pain — What the evidence actually says about cannabis for long-term pain, separated from the mark...
• Cannabis Use Disorder — A real DSM-5 diagnosis affecting roughly 1 in 5 regular users, with modest but growing evi...